Earnings

Abivax H1 EPS $(2.43) Misses $(1.08) Estimate, Sales $2.959M Beat $1.860M Estimate

Sep 21, 2026 · 04:40 PM ET· updated 3h ago

Abivax (NASDAQ:ABVX) reported quarterly losses of $(2.43) per share which missed the analyst consensus estimate of $(1.08) by 125 percent. This is a 65.31 percent decrease over losses of $(1.47) per share from the same

Why It Matters

Abivax lost more money per share than experts thought it would. Sales were good, but big losses mean the company is spending fast.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

ABVX103.11

-1.94 (-1.84%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.